Loading…
2019 NHCA Annual Conference has ended
avatar for Dr Nigel Whittle

Dr Nigel Whittle

Plextek Ltd
Head, Medical & Healthcare
Cambridge, United Kingdom
Plextek has developed an innovative technology to detect early symptoms of hearing loss by reliable and repeatable measurement of Auditory Brainstem Responses (ABR), that can be incorporated into standard commercial earbuds. The patented technology has the potential to provide early warning of imminent auditory disorders including hearing loss and tinnitus.
This work was originally funded by a UK defence contract, and we are working with Cambridge University to enhance the capabilities of the technology.
Plextek will commercialise the technology through a number of parallel approaches in different market sectors, and welcome approaches from potential collaborators.

Thursday, February 7
 

7:30am

8:30am

9:45am

11:30am

1:00pm

2:15pm

5:30pm

 
Friday, February 8
 

7:00am

8:15am

9:05am

9:25am

9:45am

10:35am

12:05pm

1:30pm

1:50pm

2:10pm

2:30pm

3:00pm

3:40pm

5:00pm

6:00pm

 
Saturday, February 9
 

7:30am

9:00am

9:25am

10:10am

10:40am

11:10am

11:30am

12:00pm

2:25pm

3:35pm

3:55pm

4:15pm

4:35pm